主要臭氧治疗对纤维肌痛综合征疾病参数的短期和中期影响:一项回顾性研究
Ahmet Üşen1,2, Didem Sezgin Özcan3, Mehmet Ağirman4
1Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Istanbul Medipol University, Istanbul, Türkiye, Turkey. ahmetusen1@hotmail.com.
Rheumatology international
|March 12, 2025
概括
臭氧治疗对纤维肌痛综合征 (FMS) 患者产生短期益处,改善疼痛和疲劳. 然而,六个月后症状复发表明需要进一步研究优化治疗方案以获得长期缓解.
科学领域:
- 综合医学是一个整体的医学.
- 疼痛管理 疼痛管理
- 康复医学 康复医学 康复医学
背景情况:
- 纤维肌痛综合征 (FMS) 是一种慢性疾病,具有广泛的疼痛,疲劳和睡眠障碍的特征.
- 对于FMS的传统治疗方法通常效果有限,这促使人们探索补充疗法.
- 臭氧疗法正在成为FMS的潜在补充治疗方法.
研究的目的:
- 追溯评估臭氧治疗在管理FMS症状中的短期和中期有效性.
- 评估臭氧治疗对FMS患者疼痛,功能状态,睡眠质量,疲劳,焦虑和抑郁症的影响.
主要方法:
- 25名FMS患者接受了10次主要臭氧自血疗法.
- 包括疼痛 (VAS),功能状态 (FIQ),焦虑/抑郁 (HADS),睡眠质量 (PSQI) 和疲劳 (FSS) 在内的结果在基线,治疗后和治疗后六个月被评估.
- 用通用估计方程来对收集的数据进行统计分析.
主要成果:
- 在治疗后观察到疼痛得分 (VAS) 和疼痛点的显著减少,在六个月后部分复发.
- 纤维肌痛影响问卷 (FIQ) 评分显示治疗后显著改善,在六个月稳定下来.
- 还注意到焦虑,抑郁,睡眠质量和疲劳的改善,反映了疼痛和功能状态的趋势.
结论:
- 臭氧疗法在缓解FMS症状方面显示出有希望的短期和中期疗效.
- 在治疗后,疼痛,功能状态和整体幸福感得到了显著改善.
- 六个月后症状的部分复发凸显了进一步研究的必要性,以优化臭氧治疗方案,以获得FMS管理中的长期持续益处.
相关概念视频
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
156
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
156
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170